title: Life threatening haemorrhagic events associated with the administration of low-molecular-weight-heparin.
authors.forename: Dara
authors.initials: D
authors.lastname: Kavanagh
authors.forename: Arnold D K
authors.initials: AD
authors.lastname: Hill
authors.forename: Sean
authors.initials: S
authors.lastname: Martin
authors.forename: Colm
authors.initials: C
authors.lastname: Power
authors.forename: Enda W
authors.initials: EW
authors.lastname: McDermott
authors.forename: Niall
authors.initials: N
authors.lastname: O'Higgins
authors.forename: Karen
authors.initials: K
authors.lastname: Murphy
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D016638:Critical Illness; D017984:Enoxaparin / Q000009:adverse effects; D005260:Female; D006470:Hemorrhage / Q000139:chemically induced*; D006495:Heparin, Low-Molecular-Weight / Q000009:adverse effects*; D006801:Humans; D008297:Male; D010146:Pain
chemical_list: D017984:Enoxaparin; D006495:Heparin, Low-Molecular-Weight